Published in J Interv Card Electrophysiol on June 01, 2001
Atrial fibrillation: what are the targets for intervention? J Interv Card Electrophysiol (2003) 0.75
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22
Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation (1999) 4.00
Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation (2000) 2.72
Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol (1995) 1.48
Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol (1999) 1.02
Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. Am J Cardiol (1999) 0.92
Direct study of left atrial P waves. Am J Cardiol (1967) 0.88
P waves during ectopic atrial rhythms in man: a study utilizing atrial pacing with fixed electrodes. Circulation (1975) 0.83
Left atrial arrhythmias. Am Heart J (1963) 0.75
Comparison of endocardial activation times at effective and ineffective ablation sites within the pulmonary veins. J Cardiovasc Electrophysiol (2000) 0.75
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Evaluating the yield of medical tests. JAMA (1982) 14.05
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53
Subclinical atrial fibrillation and the risk of stroke. N Engl J Med (2012) 11.11
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease. Circulation (1980) 7.96
Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78
Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med (1993) 5.59
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50
Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst (1988) 4.07
Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med (1997) 3.85
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol (1996) 3.47
Cardiotoxicity after accidental herb-induced aconite poisoning. Lancet (1992) 3.43
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39
Job strain and the prevalence and outcome of coronary artery disease. Circulation (1995) 3.22
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation (1998) 2.77
Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep (1985) 2.76
Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol (2000) 2.67
Clinical consequences of electrocardiographic artifact mimicking ventricular tachycardia. N Engl J Med (1999) 2.66
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol (1988) 2.59
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Characterization of cDNA sequences corresponding to three distinct HMG-1 mRNA species in line CHO Chinese hamster cells and cell cycle expression of the HMG-1 gene. Nucleic Acids Res (1987) 2.51
Physician interpretation of electrocardiographic artifact that mimics ventricular tachycardia. Am J Med (2001) 2.47
Differentiation of atypical atrioventricular node re-entrant tachycardia from orthodromic reciprocating tachycardia using a septal accessory pathway by the response to ventricular pacing. J Am Coll Cardiol (2001) 2.40
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA (1989) 2.33
Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med (1991) 2.32
Temperature monitoring during radiofrequency catheter ablation of accessory pathways. Circulation (1992) 2.31
Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? Am Heart J (2000) 2.21
Placement of electrode catheters into the coronary sinus during electrophysiology procedures using a femoral vein approach. Am J Cardiol (1994) 2.19
A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol (1999) 2.13
Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med (1999) 2.12
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA (1982) 2.08
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. Circulation (1996) 2.03
The last word on GUSTO, for now. Ann Intern Med (1994) 2.02
Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation (1992) 2.00
Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA (2000) 1.99
Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med (1987) 1.98
Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation (2000) 1.98
Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med (1994) 1.94
Long-term effect of right ventricular pacing on myocardial perfusion and function. J Am Coll Cardiol (1997) 1.94
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation (1994) 1.91
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J (1990) 1.90
Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1992) 1.88
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87
De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res (2000) 1.78
The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation (1978) 1.75
Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation (1998) 1.74
Coexistent Mahaim and Kent accessory connections: diagnostic and therapeutic implications. J Am Coll Cardiol (1987) 1.72
A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation (1997) 1.71
Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol (1985) 1.71
Nonpharmacological approaches to atrial fibrillation. Circulation (2001) 1.70
Estimating the likelihood of significant coronary artery disease. Am J Med (1983) 1.69
Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am J Hypertens (2008) 1.69
Electrogram polarity and cavotricuspid isthmus block during ablation of typical atrial flutter. J Cardiovasc Electrophysiol (2001) 1.65
Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol (2001) 1.65
Radiation exposure during radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1991) 1.62
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol (1997) 1.62
Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol (1996) 1.62
Effect of chronic amiodarone therapy on defibrillation energy requirements in humans. J Cardiovasc Electrophysiol (2000) 1.59
A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Circulation (1991) 1.58
Interference from a hand held radiofrequency remote control causing discharge of an implantable defibrillator. Pacing Clin Electrophysiol (1993) 1.57
Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol (1992) 1.57